Tadocizumab, CAS 339086-80-5

Product Description: Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research[1][2].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]S Kaku, et al. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys. Thromb Haemost. 1996 Apr;75(4):679-84./[2]Ken-ichi Suzuki, et al. Comparative studies of a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, and abciximab on in vitro antiplatelet effect and binding properties. Biol Pharm Bull. 2002 Aug;25(8):1006-12.

CAS Number: 339086-80-5

Molecular Weight: N/A

Research Area: Cardiovascular Disease

Solubility: 10 mM in DMSO

Target: Integrin

• Artikelnummer: MEXHY-P99560-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99560-5
• Verpackungseinheit: 5mg
• Mengeneinheit: STK
• Konjugat: Unconjugated